NCT06158347View on ClinicalTrials.gov

Efficacy and Safety of Hyperbaric Oxygen Therapy for Radiation Dermatitis in Patients with Localized Breast Cancer

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 6, 2023

Primary Completion Date

September 6, 2024

Study Completion Date

September 25, 2024

Conditions
Breast CancerRadiation Dermatitis
Interventions
DEVICE

hyperbaric oxygen chamber

Hyperbaric oxygen therapy allows patients to breathe 100% oxygen through an O2 Fresh M50 (HBOT Medical, Wonju, South Korea) chamber. Upon entering the chamber, oxygen is supplied by gradually increasing the barometric pressure from normal pressure to 1.5 atmospheres absolute (ATA).

Trial Locations (1)

10414

Lee Jee Young, Goyang-si

All Listed Sponsors
lead

Ilsan Cha hospital

OTHER

NCT06158347 - Efficacy and Safety of Hyperbaric Oxygen Therapy for Radiation Dermatitis in Patients with Localized Breast Cancer | Biotech Hunter | Biotech Hunter